Indications for LEXETTE:

Plaque psoriasis.


≥18yrs: Apply a thin layer to affected areas twice daily for up to 2 weeks; max 50g/week. Discontinue when control is achieved. Reevaluate if no improvement within 2 weeks. Treatment beyond 2 consecutive weeks: not recommended. Do not occlude.


<18yrs: not established.


Not for ophthalmic, oral, or intravaginal use. Avoid use near eyes, on face, groin, or axillae. Risk of HPA axis suppression with high-potency steroids, prolonged use, application to large surface area, occlusive use, altered skin barrier, concomitant multiple corticosteroid-containing products, liver failure, young age; discontinue gradually, reduce dose, or substitute with less potent corticosteroid if occurs. Increased risk of posterior subcapsular cataracts and glaucoma. Treat infection if present or develop; discontinue until infection resolved. Discontinue if allergic contact dermatitis occurs. Flammable. Reevaluate periodically. Pregnancy. Nursing mothers: avoid direct infant exposure.

Pharmacologic Class:


Adverse Reactions:

Application site pain, headache; local adverse reactions (eg, atrophy, striae, telangiectasias, burning, itching, irritation, dryness, folliculitis, acneiform eruptions, hypopigmentation, dermatitis, secondary infection, miliaria), Cushing's syndrome, glucosuria, HPA axis suppression (esp. in children).

Generic Availability:


How Supplied:

Foam—50g, 100g

Pricing for LEXETTE

50g of 0.05% can of foam (Qty: 1)
Appx. price $855